Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage alzheimer’s disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Neurotoxicity research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.1007/BF03033884PMID 16179263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Neuropathologic substrate of mild cognitive impairment.

  2006cited by this paper
• Electron microscopical localization of the zinc in hippocampal mossy fibre synapses by a modified sulfide silver procedure

  2004cited by this paper
• Overview of mammalian zinc transporters

  2003cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• ZnT7, a Novel Mammalian Zinc Transporter, Accumulates Zinc in the Golgi Apparatus*

  2003cited by this paper
• Zinc-enriched (ZEN) terminals in mouse olfactory bulb.

  2000cited by this paper
• Importance of zinc in the central nervous system: the zinc-containing neuron.

  2000cited by this paper
• Elimination of zinc from synaptic vesicles in the intact mouse brain by disruption of the ZnT3 gene.

  1999cited by this paper
• Mild Cognitive Impairment Clinical Characterization and Outcome

  1999cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Characterization of zinc-induced neuronal death in primary cultures of rat cerebellar granule cells.

  1997cited by this paper
• A novel gene involved in zinc transport is deficient in the lethal milk mouse

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material.

  1997cited by this paper
• Zinc metabolism in the brain: relevance to human neurodegenerative disorders.

  1997cited by this paper
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Zinc neurotoxicity may contribute to selective neuronal death following transient global cerebral ischemia.

  1996cited by this paper
• Distribution of terminal fields stained for zinc in the neocortex of the rat.

  1996cited by this paper
• Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress.

  1996cited by this paper
• ZnT‐2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration.

  1996cited by this paper
• ZnT-3, a putative transporter of zinc into synaptic vesicles.

  1996cited by this paper
• Expression and regulation of brain metallothionein.

  1995cited by this paper
• Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc.

  1995cited by this paper
• The function of metallothionein.

  1995cited by this paper
• Elemental imbalances in the olfactory pathway in Alzheimer's disease.

  1995cited by this paper
• Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient.

  1995cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• The biochemical basis of zinc physiology.

  1993cited by this paper
• MT-III, a brain-specific member of the metallothionein gene family.

  1992cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains.

  1990cited by this paper
• An Introduction to the Biochemistry of Zinc

  1989cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

  1989cited by this paper
• Zinc in Cell Division and Tissue Growth: Physiological Aspects

  1989cited by this paper
• Brain trace elements in Alzheimer's disease.

  1986cited by this paper
• Release of zinc sulphide accumulations into synaptic clefts after in vivo injection of sodium sulphide.

  1986cited by this paper
• Intravesicular localization of zinc in rat telencephalic boutons. A histochemical study.

  1985cited by this paper
• The dithizone, Timm's sulphide silver and the selenium methods demonstrate a chelatable pool of zinc in CNS

  1985cited by this paper
• Release of endogenous Zn2+ from brain tissue during activity

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Cytoarchitectonic distribution of zinc in the hippocampus of man and the rat.

  1983cited by this paper
• A critical physiological role of zinc in the structure and function of biomembranes.

  1981cited by this paper
• Abnormal tubulin aggregates induced by zinc sulfate in organotypic cultures of nerve tissue.

  1978cited by this paper

• ZnT3-TMEM163 Mediates Zinc Homeostasis Imbalance Induced Neurodegeneration in Hippocampus.

  2025cites this paper
• Zinc Transporters in diseases, including diabetes and related conditions.

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases

  2025cites this paper
• ZnTs: Key Regulators of Zn2+ Homeostasis in Diseases

  2025cites this paper
• Structural insights into human zinc transporter ZnT1 mediated Zn2+ efflux

  2024cites this paper
• Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease.

  2024cites this paper
• Structural insights into the calcium-coupled zinc export of human ZnT1

  2024cites this paper
• Unlocking the brain’s zinc code: implications for cognitive function and disease

  2024cites this paper
• Distribution of Copper, Iron, and Zinc in the Retina, Hippocampus, and Cortex of the Transgenic APP/PS1 Mouse Model of Alzheimer’s Disease

  2023cites this paper
• Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases.

  2023cites this paper
• Differential expression of SLC30A10 and RAGE in mouse pups by early life lead exposure.

  2023cites this paper
• Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine

  2023influential citation
• Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases

  2022cites this paper
• Zinc in Cognitive Impairment and Aging

  2022influential citation
• The ZIP3 Zinc Transporter Is Localized to Mossy Fiber Terminals and Is Required for Kainate-Induced Degeneration of CA3 Neurons

  2022cites this paper
• Metal transport mechanism of the cation diffusion facilitator (CDF) protein family – a structural perspective on human CDF (ZnT)-related diseases

  2021cites this paper
• The plasma peptides of Alzheimer’s disease

  2021cites this paper
• Heterologous Expression and Biochemical Characterization of the Human Zinc Transporter 1 (ZnT1) and Its Soluble C-Terminal Domain

  2021cites this paper
• Zinc binding alters the conformational dynamics and drives the transport cycle of the cation diffusion facilitator YiiP

  2021cites this paper
• Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy.

  2020cites this paper
• Peroxidase activity of heme bound amyloid β peptides associated with Alzheimer's disease.

  2020cites this paper
• Zinc Dependent Conformational Changes in the Cation Diffusion Facilitator YiiP from S. oneidensis

  2020cites this paper
• The Role of the SLC Transporters Protein in the Neurodegenerative Disorders

  2020cites this paper
• Zinc transporters in Alzheimer’s disease

  2019cites this paper
• A structural overview of the zinc transporters in the cation diffusion facilitator family

  2019cites this paper
• Brain Energy and Oxygen Metabolism: Emerging Role in Normal Function and Disease

  2018cites this paper
• Biometals and Alzheimer’s Disease

  2017cites this paper
• Zinc as a Gatekeeper of Immune Function

  2017cites this paper
• Translational Informatics in Smart Healthcare

  2017cites this paper
• Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus

  2017cites this paper
• Trace Elements and Healthcare: A Bioinformatics Perspective.

  2017cites this paper
• Regulation of Zn2+ and aggregation affects Aβ1-42- induced changes in cell culture viability.

  2017cites this paper
• Targeting Transition Metals for Neuroprotection in Alzheimer’s Disease

  2017cites this paper
• Metals in Alzheimer’s and Parkinson’s Disease: Relevance to Dementia with Lewy Bodies

  2016cites this paper
• Disruption of brain zinc homeostasis promotes the pathophysiological progress of Alzheimer's disease.

  2016cites this paper
• Obesity and age-related alterations in the gene expression of zinc-transporter proteins in the human brain

  2016cites this paper
• Meta‐analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

  2016cites this paper
• Novel zinc-targeted therapeutic options for cognitive decline

  2015cites this paper
• Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity

  2015cites this paper
• Biological metals and metal-targeting compounds in major neurodegenerative diseases.

  2014cites this paper
• Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder

  2014cites this paper
• The families of zinc (SLC30 and SLC39) and copper (SLC31) transporters.

  2014cites this paper
• Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology

  2014cites this paper
• Altered Expression of ZnT10 in Alzheimer's Disease Brain

  2013influential citation
• Metallostasis in Alzheimer's disease.

  2013cites this paper
• Altered Expression of ZnT 10 in Alzheimer ’ s Disease Brain

  2013influential citation
• Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis

  2013cites this paper
• Zinc and the aging brain

  2013cites this paper
• Zinc homeostasis and neurodegenerative disorders

  2013cites this paper
• The SLC30 family of zinc transporters - a review of current understanding of their biological and pathophysiological roles.

  2013cites this paper
• Micronutrients in elderly

  2013cites this paper
• Les micronutriments chez le sujet vieillissant

  2013cites this paper
• Les micronutriments chez le sujet vieillissant Micronutrients in elderly

  2013cites this paper
• Synaptic Released Zinc Promotes Tau Hyperphosphorylation by Inhibition of Protein Phosphatase 2A (PP2A)*

  2012cites this paper
• Heterologous production and characterisation of cation diffusion facilitator proteins from the marine bacterium Maricaulis maris MCS10

  2012cites this paper
• Characterisation of the zinc transporter ZnT10 and its role in cellular homeostasis in healthy and Alzheimer's disease brain

  2012influential citation
• Bioinorganic chemistry of Alzheimer's disease.

  2012cites this paper
• Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases)

  2012cites this paper
• Zinc Transporter mRNA Levels in Alzheimer's Disease Postmortem Brain

  2012cites this paper
• The inorganic perspectives of neurotrophins and Alzheimer's disease.

  2012cites this paper
• The neuropathological profile of mild cognitive impairment (MCI): a systematic review

  2012cites this paper
• Brain zinc metabolism and Alzheimer's disease

  2012cites this paper
• A potential role for zinc alterations in the pathogenesis of Alzheimer's disease

  2012cites this paper
• Modest Amyloid Deposition is Associated with Iron Dysregulation, Microglial Activation, and Oxidative Stress

  2012cites this paper
• Brain zinc metabolism and Alzheimer’s disease

  2012influential citation
• Neuropathological Profile of Mild Cognitive Impairment From a Population Perspective

  2012cites this paper
• Micronutrient status and cognitive decline in ageing

  2011cites this paper
• Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain.

  2010cites this paper
• Alterations of Zinc Transporter Proteins ZnT‐1, ZnT‐4 and ZnT‐6 in Preclinical Alzheimer's Disease Brain

  2010cites this paper
• Short-term effects of zinc on acetylcholine metabolism and viability of SN56 cholinergic neuroblastoma cells.

  2010cites this paper
• Zinc-induced Neurotoxicity Mediated by Transient Receptor Potential Melastatin 7 Channels*

  2010cites this paper
• Zinc Overload Enhances APP Cleavage and Aβ Deposition in the Alzheimer Mouse Brain

  2010cites this paper
• The Role of Zinc in Alzheimer's Disease

  2010cites this paper
• Distribution and progression of amyloid-beta deposits in the amygdala of the aged macaque monkey, and parallels with zinc distribution.

  2009cites this paper
• Zinc Contribution to the Regulation of Glucose Disposal, Lipid Metabolism and Striated Muscle Contractions

  2009cites this paper
• Fonctions des oligoéléments et besoins spécifiques de la personne âgée

  2009cites this paper
• ALTERA TIONS OF ZINC TRAN SPORTERS IN ALZHEIMER'S DISEASE

  2009cites this paper
• ALTERATIONS OF ZINC TRANSPORTERS IN ALZHEIMER'S DISEASE

  2009influential citation
• Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.

  2008cites this paper
• Spatially resolved and bulk zinc analysis in biological samples of patients at different stages of Alzheimer's disease by high resolution inductively coupled plasma mass spectrometry

  2008cites this paper
• Expression of ZnT and ZIP zinc transporters in the human RPE and their regulation by neurotrophic factors.

  2008cites this paper
• Serum Zinc in the Progression of Alzheimer's Disease

  2008influential citation
• bundant expression of zinc transporters in the amyloid plaques f Alzheimer’s disease brain

  2008cites this paper
• Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.

  2008cites this paper
• Studies of zinc transport and its contribution to zinc homeostasis in cultured cortical neurons.

  2008cites this paper
• Metal Ions and Alzheimer's Disease

  2007cites this paper
• Chapter 3 – Genetic and Environmental Factors in Neurodegenerative Diseases

  2007cites this paper
• Age-dependent oxidation and aggregation of ZnT-1: a role for metal catalyzed oxidation?

  2007cites this paper
• Zinc fluxes and zinc transporter genes in chronic diseases.

  2007cites this paper
• Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.

  2007cites this paper
• Role of zinc in ALS

  2007cites this paper
• Neurotoxins and neurotoxicity mechanisms. an overview

  2006cites this paper
• Elevated Zinc Transporter-6 in Mild Cognitive Impairment, Alzheimer Disease, and Pick Disease

  2006cites this paper
• Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.

  2006cites this paper
• Metals and Alzheimer's disease

  2006cites this paper